Clinical Trials
460 trialsCollection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
ASCaP
Jonsson Comprehensive Cancer Center
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Jonsson Comprehensive Cancer Center
23146
Bayer
Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
University of Limerick
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
IRONMAN
Prostate Cancer Clinical Trials Consortium
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
National Institutes of Health Clinical Center (CC)
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
National Institutes of Health Clinical Center (CC)
RECOVER
Comprehensive Cancer Centre The Netherlands
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Oslo University Hospital
LEARN
University of Sydney
HAYATE
Bayer
TARA
Bayer
T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
University Hospital, Basel, Switzerland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
University of Washington
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Thomas Jefferson University
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Novartis
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
National Institutes of Health Clinical Center (CC)
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Astellas Pharma Inc
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Bayer
SELECT
University of Manchester
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Nova-sTAR
Janssen Research & Development, LLC
OBSAPA
Janssen Cilag S.A.S.
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
National Institutes of Health Clinical Center (CC)
OASIS
Sheffield Teaching Hospitals NHS Foundation Trust
PEP-C
Centre Hospitalier Universitaire de Saint Etienne
iCaRe2
University of Nebraska
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
CHLOECAPA
Institut National de la Santé Et de la Recherche Médicale, France
SR-ULM BC
Duke University
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Duke University
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Prostate Cancer
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
TVNIM-AFU
Association Francaise d'Urologie
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
National Institutes of Health Clinical Center (CC)
AI-based Measurements of Tumour Burden in PSMA PET-CT
Skane University Hospital
PRO-MIND
Ankara Etlik City Hospital
EXO-MET
Xijing Hospital
PSMA-TM
Xijing Hospital
PROWESs
AstraZeneca
AkkPRO
Assistance Publique - Hôpitaux de Paris